Pretraživanje
Prikaz rezultata 1-1 od 1
Overview of COA Measures in SLE Clinical Trials and Label Claims
(Elsevier, 2023)
Background
Systematic lupus erythematosus (SLE) is a condition linked with high symptom burden and severe quality of life (QoL) impacts. The FDA and EMA SLE guidance recommends inclusion of clinical outcome assessments ...